• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    More On VRNM

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Verenium Corporation (VRNM)

    -NasdaqGM
    3.99 0.00(0.00%) Oct 31
    Add to Portfolio
    Prev Close:3.99
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:4.00
    Beta:0.47
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:2.00 - 4.00
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for VRNM at this time.

    Comparison

    Symbol% ChgMkt Cap
    VRNM 0.00%N/A
    CDXSUp 13.60%102.43M
    DDUp 2.39%63.65B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Sep-13) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Verenium Corporation, an industrial biotechnology company, engages in the development and commercialization of enzymes for industrial processes in North America, Europe, South America, and Asia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback